Y-mAbs(YMAB) - 2022 Q1 - Earnings Call Transcript

Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2022 Results Conference Call May 10, 2022 9:00 AM ET Company Participants Thomas Gad - Founder, Interim CEO and President Bo Kruse - CFO Sue Smith - Chief Commercial Officer Vignesh Rajah - Chief Medical Officer Dr. Steen Lisby - Chief Scientific Officer Conference Call Participants Alec Stranahan - Bank of America Joseph Thome - Cowen & Company Charles Zhu - Guggenheim Mike Ulz - Morgan Stanley Tessa Romero - JP Morgan Sebastiaan van der Schoot - Kempen Operator G ...